EphrinB2 induces tyrosine phosphorylation of NR2B via Src-family kinases during inflammatory hyperalgesia  by Slack, S. et al.
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OphrinB2 INDUCES TYROSINE PHOSPHORYLATION OF NR2B VIA
rc-FAMILY KINASES DURING INFLAMMATORY HYPERALGESIA
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bstract—In recent years a role for EphB receptor tyrosine
inases and their ephrinB ligands in activity-dependent syn-
ptic plasticity in the CNS has been identified. The aim of the
resent study was to test the hypothesis that EphB receptor
ctivation in the adult rat spinal cord is involved in synaptic
lasticity and processing of nociceptive inputs, through
odulation of the function of the glutamate ionotropic recep-
or NMDA (N-methyl-D-aspartate). In particular, EphB recep-
or activation would induce phosphorylation of the NR2B
ubunit of the NMDA receptor by a Src family non-receptor
yrosine kinase. Intrathecal administration of ephrinB2-Fc in
dult rats, which can bind to and activate EphB receptors and
nduce behavioral thermal hyperalgesia, led to NR2B tyrosine
hosphorylation, which could be blocked by the Src family
inase inhibitor PP2. Furthermore animals pre-treated with
P2 did not develop behavioral thermal hyperalgesia follow-
ng EphrinB2-Fc administration, suggesting that this pathway
s functionally significant. Indeed, EphB1-Fc administration,
hich competes with the endogenous receptor for ephrinB2
inding and prevents behavioral allodynia and hyperalgesia
n the carrageenan model of inflammation, also inhibited
R2B phosphorylation in this model. Taken together these
ndings support the hypothesis that EphB– ephrinB interac-
ions play an important role in NMDA-dependent, activity-
ependent synaptic plasticity in the adult spinal cord, induc-
ng the phosphorylation of the NR2B subunit of the receptor
ia Src family kinases, thus contributing to chronic pain
tates. © 2008 IBRO. Published by Elsevier Ltd. 
ey words: EphB receptor, pain, plasticity, NMDA, Src, rat.
onotropic NMDA (N-methyl-D-aspartate) receptors are
ell established as a key component of nociceptive sig-
aling mechanisms in the dorsal horn of the spinal cord
nd are largely implicated in the establishment of central
ensitization, one of the primary mechanisms responsible
or development and maintenance of chronic pain (Woolf
nd Thompson, 1991; Ren and Dubner, 1999; Willis, 2001;
arsons, 2001; Petrenko et al., 2003; Bleakman et al.,
006). NMDA receptor activation has thus been implicated
n synaptic plasticity in the dorsal horn of the spinal cord,
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bbreviations: CaMKII, calcium-calmodulin kinase II; LTP, long-term
otentiation; NMDA, N-methyl-D-aspartate; PP2, 4-amino-5-(4-chloro-
henyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine; pY-NR2B, NR2B phos-
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horylated in tyrosine; SDS, sodium dodecyl sulfate; TBST, TBS con-
aining 0.1% Tween-20.
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Open access under CC BY licenss well as in the hippocampus (see e.g. Muller et al., 1988;
accaferri and McBain, 1996; Berberich et al., 2007). In
oth systems, recent studies have revealed an important
ole for the NR2B subunit of this receptor as a major
odulatory unit, controlling the activity of the receptor via
hosphorylation mechanisms, enabling synaptic potentia-
ion (long-term potentiation, LTP, or central sensitization)
Rosenblum et al., 1996; Guo et al., 2002). Modulation
ccurs through phosphorylation of the intracellular portion
f NR2B at specific tyrosine residues by signal transduc-
ion proteins. In the spinal cord, studies by Guo et al.
2002) revealed that chronic inflammatory pain induced by
omplete Freund’s adjuvant in the rat paw caused an
ncrease in the phosphorylation state of NR2B. This could
e prevented by intrathecal administration of inhibitors of
he signaling kinases Src and PKC and of group I metabo-
ropic glutamate and NK1 receptors, revealing that in this
odel NR2B could be modulated by glutamatergic and
achykinin nociceptive transmission, leading to hyperalge-
ia.
Recent studies have identified a possible role of EphB
eceptor tyrosine kinases as further modulators of NMDA
eceptor function. EphB receptors and their ephrinB li-
ands are transmembrane cell surface molecules, with a
ell-studied and important role in neural development,
rimarily acting as patterning and guidance cues (Wilkin-
on, 2001).
In the mature nervous system, several studies have
eported a neuromodulatory role for EphB receptors and
phrinBs in activity-dependent synaptic plasticity in the
NS, mainly but not exclusively via an interaction with
onotropic glutamate receptors (Henderson et al., 2001;
runwald et al., 2001; Contractor et al., 2002; Takasu et
l., 2002; Grunwald et al., 2004) reviewed in Yamaguchi
nd Pasquale (2004) and Caló et al. (2006). We previously
dentified a novel role for ephrinB2 and its Eph tyrosine
inase receptor(s) in vivo in the spinal cord, as neuro-
odulators of pain signaling, probably acting via NMDA
eceptors (Battaglia et al., 2003).
Interestingly, Takasu et al. (2002) showed that in
rimary cortical neurons in culture EphB activation by
phrinB2-Fc (immunoglobulin Fc fusion protein of ephrinB2)
nduced Src-dependent NR2B phosphorylation and fur-
hermore we showed that intrathecal injection of eph-
inB2-Fc induces Src phosphorylation in the spinal cord of
dult rats (Battaglia et al., 2003).
We therefore formulated the hypothesis that EphB re-
eptors are involved in synaptic plasticity in vivo in the
pinal cord (underlying chronic pain states) via a mecha-
ism involving Src activation and NR2B phosphorylation.
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S. Slack et al. / Neuroscience 156 (2008) 175–183176n the present study we tested this hypothesis using two
odels, ephrinB2-Fc intrathecal administration to induce
harmacological activation of the EphB receptors, and
ntraplantar carrageenan injection (a model of inflamma-
ion, which leads to NMDA-dependent central sensitization
nd behavioral hyperalgesia and allodynia, through mech-
nisms deemed analogous to those involved in the onset
f forms of chronic pain (Eisenberg et al., 1994).
EXPERIMENTAL PROCEDURES
ll experiments were performed in accordance with institutional
egulations and the Animals (Scientific Procedures) Act 1986.
very effort was made to minimize animal suffering, and the
xperiments were designed in order to use the minimum number
f animals necessary to obtain valid results.
n vivo application of neurochemicals
ntrathecal cannulae were implanted for delivery of the different
eurochemicals used in this study in domitor (250 mg/kg) and
etamine (60 mg/kg, i.p.) -anesthetized adult male Wistar rats
Harlan, Blackthorn, Bicester, UK; 225–250 g body weight).
riefly, the mid-thoracic spinal cord was incised at the midline,
uscles were separated from bone by blunt dissection, and a
mall laminectomy was made at the 6th or 7th thoracic vertebra.
cannula was inserted under the dura mater such that the tip
ested at the lumbar enlargement. The opposite end was exter-
alized at the top of the head. Catheters were prepared to allow
or an injection volume of 10 l of the test substance, followed by
10 l flush of saline solution. The application of neurochemicals
ook place after a minimum of 1 week in lightly restrained animals.
For the biochemical and behavioral studies investigating the
ffect of inhibiting Src family kinases, the rats received a bolus
ntrathecal injection of 10 l 4-amino-5-(4-chlorophenyl)-7-(t-bu-
yl)pyrazolo[3,4-d]pyrimidine (PP2, Calbiochem, San Diego, CA,
SA, 73 nmol or 7.3 nmol/rat) in DMSO (10% in saline solution) or
MSO (10% in saline solution), followed by a 10 l saline solution
ush per animal.
This was followed after 5 min by a further injection with 10 l
phrinB2-Fc solution (2 g/rat, R&D Systems, Minneapolis, MN,
SA) or saline solution (10 l), followed by a 10 l saline solution
ush per animal.
For the biochemical studies on carrageenan-treated rats, in-
ammation was induced by intraplantar injection of 100 l of
ambda carrageenan (10 mg/ml, Sigma-Aldrich, Gillingham, UK) in
ne hind paw of restrained rats. Five minutes prior to carrageenan
njection, the rats received an intrathecal injection of either
phB1-Fc (R&D Systems; 10 g/rat in saline solution), or human
gG (2 g/rat Fc fragment, Jackson Immunochemicals, West
rove, PA, USA), followed by 10 l saline solution flush. Animals
hich had received a saline injection in the hind paw were used as
ontrols.
EphB1-Fc and EphrinB2-Fc chimeric proteins migrate respec-
ively as an approximately 110 kDa protein and as an approxi-
ately 60–65 kDa protein in SDS-PAGE under reducing condi-
ion.
ehavioral studies
atheters were chronically implanted into the lumbar subarach-
oid space of anesthetized rats, as described above. Paw with-
rawal latency to a radiant heat stimulus was measured using a
lantar Test apparatus (Ugo Basile, Comerio, Italy), in which
lantar hind paws were exposed to a radiant heat stimulus and
ithdrawal latencies automatically timed. Cutoff time was 25 s.
nimals were habituated to the test environment for 3–5 days prior oo experimentation. On the day of testing, after acclimatization
riplicate measurements of withdrawal latency were taken to pro-
ide the baseline. After administration of PP2 and EphrinB2-Fc or
ehicle as described above, triplicate measurements of with-
rawal latencies were taken at each time point. Paw withdrawal
esponses were measured at 30, 60, 90, 120 min after intrathecal
njection. The experimental groups were as follows: DMSO 10% in
aline-ephrinB2-Fc (R&D Systems; n5), PP2 73 nmol (Calbio-
hem)-saline (n7), PP2 73 nmol-ephrinB2-Fc (n7), PP2
.3 nmol-ephrinB2-Fc (n6). Thermal hyperalgesia was defined
s a significant decrease of paw withdrawal latency compared
ith baseline or control values.
iochemical studies
orty minutes after intrathecal application of neurochemicals
nd/or carrageenan intraplantar injection, rats were anesthetized
ith pentobarbital (140 mg/kg) and the spinal cords were rapidly
btained by hydraulic extrusion. The dorsal horns of the lumbar
nlargement were dissected out on ice and were then immediately
nap-frozen on liquid nitrogen. They were homogenized in ice-
old lysis buffer containing protease and phosphatase inhibitors
1%v/v nonidet P-40, 2 mM EDTA, 20 mM Tris, pH 8, 137 mM
aCl, 10% v/v glycerol, 1 mM phenylmethanesulfonyl fluoride
PMSF), 5 mM NaF, 1 mM NaVO4, 10 g/ml each anti-pain,
eupeptin and pepstatin). The samples were left to homogenize for
h under rotating agitation. The extracts were centrifuged and the
upernatant retained. After protein titration using a BCA protein
ssay (Pierce, Rockford, IL, USA) the equivalent of 500 g of total
rotein was added to 5 g of rabbit anti-NR2B (Upstate, Cam-
ridge, UK) antibody and gently shaken overnight at 4 °C.
The next morning protein-A sepharose beads were added to
he samples and gently shaken for 4 h at 4 °C. Beads were then
insed in lysis buffer and boiled in loading buffer made of 2%
odium dodecyl sulfate (SDS), 100 mM DTT, 10% glycerol, 0.25%
romophenol Blue for 5 min. The protein-rich supernatant was
eparated on an 8% acrylamide resolving gel and transferred to a
VDF membrane using a semi-dry transfer unit (BioRad, Her-
ules, USA). After 1 h transfer in 20% methanol transfer buffer the
embranes were blocked in 5% BSA in TBS containing 0.1%
ween-20 (TBST) and were incubated overnight at room temper-
ture in either mouse anti–phospho tyrosine (4G10) antibody
diluted 1:1000) (Upstate) or rabbit anti-phospho-Src antibody
diluted 1:1000) (Biosource, Paisley, UK), or rabbit anti phospho-
yr1472-NR2B (Imgenex, Sorrento Valley, CA, USA) or rabbit anti
hospho-Ser1303-NR2B (Upstate) or rabbit anti-EphB1 (1:200,
anta Cruz Biotechnology, Santa Cruz, CA, USA). Blots were
ashed in TBST and incubated in peroxidase-conjugated donkey
nti-rabbit IgG (1:5000, Amersham Pharmacia, Chalfont St.Giles,
K) or donkey anti-mouse IgG (1:10,000, Amersham Pharmacia)
or 1 h at room temperature. All antibodies were diluted in TBST.
Protein bands were visualized using an enhanced chemi-
uminescence detection kit (ECL Plus) (Amersham Pharmacia)
ollowed by autoradiography using Hyperfilm MP (Amersham
harmacia). The blots were then washed in TBST and stripped for
5 min in stripping buffer (2% w/v SDS, 0.8% v/v -mercaptoetha-
ol, 12.5% w/v Tris–HCl, pH 6.8, 0.5 M). The membranes were
ashed for 2 h in a continuous flow of water and blocked in 5%
SA in TBST for 1 h. Membranes were reprobed for total NR2B by
vernight incubation at room temperature in rabbit anti-NR2B
Upstate). Blots were then washed, incubated for 1 h with sec-
ndary antibody (peroxidase-conjugated donkey anti-mouse IgG,
:5000, Amersham Pharmacia) and visualized as above. Gels
ere scanned and captured using Adobe Photoshop (Adobe Sys-
ems Inc., San Jose, CA, USA). The densitometric analysis was
ade using Scion Image software (Scion Corporation, Fredrick,
D, USA) by measuring the surface area of the band (pixel
quares) as well as the average pixel intensity (using a gray scale
f 256 levels) for each band. Results were expressed as the level
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S. Slack et al. / Neuroscience 156 (2008) 175–183 177f phosphorylation for each sample i.e. as the ratio (in arbitrary
nits) of the phosphorylated form (phospho-tyrosine-NR2B/phos-
ho-Src/phospho-Ser1303/phospho-Tyr1472) over total form of
R2B.
tatistical analysis of data
tatistical analysis was performed using an ANOVA on ranks
ethod for the analysis of bands on membranes, while two-way
NOVA and post hoc Bonferroni tests were used for behavioral
ata analysis. All analysis was performed using SigmaStat soft-
are (Systat Software Inc., San Jose, CA, USA). P values less
han 0.05 were taken as significant.
RESULTS
ntrathecally administered ephrinB2 induces NR2B
hosphorylation via Src
e have previously shown that a single intrathecal injec-
ion of ephrinB2 could induce thermal hyperalgesia in rats
ithin 30 min, which could be prevented by co-administra-
ion of the NMDA receptor antagonist MK801 (Battaglia et
l., 2003). These data strongly suggested the involvement
f this glutamate receptor in ephrinB2-mediated nocicep-
ive processing.
Here we wished to investigate whether the modulatory
ffect of ephrinB2 on NMDA receptor could be via intra-
ellular tyrosine phosphorylation of the NR2B subunit. Dor-
ig. 1. Effect of ephrinB2 treatment on phosphorylation of NR2B. NR2
ats, which had received two intrathecal injections, separated by a 5 m
r the Src family kinases inhibitor PP2 (73 nmol in DMSO 10% in saline
r 10 l saline solution. The state of phosphorylation of NR2B at vari
ntibodies. (A) Representative immunoblots using anti-phosphotyros
hosphorylation of NR2B were significantly increased following ephrin
revented by prior administration of PP2 (n4). (B) EphrinB2-Fc tre
yr1472. The top blot shows the immunoreactive bands against phos
arget of phosphorylation on NR2B following ephrinB2-Fc treatment, an
f phosphorylation of NR2B on Ser1303 residue (shown in the hippo
ffected by treatment with ephrinB2-Fc. Immunoblots obtained using
R2B; n3 for all groups. In all bar charts the relative phosphoprotei
nd normalized to the respective NR2B band. In all experiments leve
n Experimental Procedures. Test: ANOVA on ranks. * P0.05.al horn cord samples of saline (control) or ephrinB2 preated rats were immunoprecipitated with an NR2B sub-
nit-specific antibody, eluted and incubated with a phos-
ho-tyrosine specific antibody (4G10, i.e. NR2B phosphor-
lated in tyrosine (pY-NR2B) in Fig. 1A). The band was at
he correct molecular weight for NR2B and was also rec-
gnized by a total NR2B specific antibody (Fig. 1A).
Following ephrinB2 treatment, the state of tyrosine
hosphorylation of NR2B was significantly increased com-
ared with control levels, while levels of total NR2B re-
ained unchanged (Fig. 1A lanes 1 and 2). Administration
f PP2, which inhibits the Src family of protein tyrosine
inases, prior to administration of ephrinB2, prevented the
ncrease in NR2B tyrosine phosphorylation (Fig. 1A lane 3
s. lane 1 and 2). PP2 alone did not alter NR2B basal
hosphorylation levels (data not shown).
We further investigated whether residue Tyr1472 of
R2B could be the target of ephrinB2 signaling, by immu-
oprecipitating NR2B and probing with an antibody spe-
ific for the phosphorylated form of Tyr1472. In the mouse
elencephalon, this residue was shown to be phosphory-
ated by a Src family member named Fyn (Nakazawa et al.,
001). Phosphorylation levels of Tyr1472 were signifi-
antly increased following ephrinB2 treatment (Fig. 1B), an
ffect which could be prevented by prior administration of
P2, suggesting a signal cascade involving Src family
inases was involved in ephrinB2 modulation of Tyr1472
munoprecipitated from the dorsal portion of the lumbar spinal cord of
al. The first injection was either vehicle (DMSO 10% in saline, 10 l)
nd the second injection was either ephrinB2-Fc (2 g in saline, 10 l),
ues was observed in immunoblots performed using phospho-specific
0 (pY-NR2B) followed by anti-NR2B antibodies. Levels of tyrosine
atment (n4) compared with control levels (n4). This increase was
nduced phosphorylation of the NR2B subunit of NMDA receptor on
472, while the bottom blot shows total NR2B. Tyr1472 residue was a
osphorylation was blocked by PP2; n4 for all groups. (C) The levels
o be phosphorylated by CaMKII) in the lumbar spinal cord were not
es specific for phospho-Ser1303 (top panel) and antibodies against
meansS.E.M.) are expressed as percentage of the saline controls,
NR2B remained unchanged. Quantification carried out as describedB was im
in interv
, 10 l), a
ous resid
ine 4G1
B2-Fc tre
atment i
pho-Tyr1
d this ph
campus t
antibodi
n levels (hosphorylation.
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S. Slack et al. / Neuroscience 156 (2008) 175–183178It has been reported that specific serine residues on
R2B can also be modulated by protein kinases in the
ippocampus: the Ser1303 residue was shown to be phos-
horylated by calcium-calmodulin kinase II (CaMKII), to
nable a slower dissociation of preformed CaMKII–NR2B
omplexes, a component of synaptic plasticity (Omkumar
t al., 1996; Strack and Colbran, 1998; Strack et al., 2000).
e therefore investigated whether ephrinB2 could alter the
tate of phosphorylation of Ser1303. Immunoprecipitation
f NR2B followed by probing with the phospho-Ser1303-
R2B-specific antibody revealed no change compared
ith control levels (Fig. 1C). This therefore suggests that
either CaMKII nor modulation of Ser1303 phosphoryla-
ion is involved in ephrinB2 modulation of NMDA receptor
ctivity.
he pro-nociceptive effects of ephrinB2 are mediated
y Src-family kinases
e have recently shown in the spinal cord an increase in
he state of phosphorylation of non-receptor Src-family
yrosine kinases which were bound to EphB receptors
pulled-down” following ephrinB2 treatment (Battaglia et
l., 2003). Furthermore, here we have shown that the
rc-family kinase inhibitor PP2 could prevent ephrinB2
nduction of NR2B phosphorylation. These data suggest
hat Src-family kinases are likely candidates for mediating
ig. 2. Effect of ephrinB2-Fc intrathecal treatment on the levels of pho
eceived two consecutive intrathecal injections (separated by a 5 min
P2 (73 nmol only for immunoprecipitation, 73 or 7.3 nmol for behavio
f either ephrinB2-Fc (2 g in saline) or saline only. (A) NR2B was im
reated rats. The top panel shows representative immunoblots perform
f phospho-Src co-precipitated with NR2B were significantly increase
his increase was not present in rats pre-treated with PP2 (n3). In th
s percentage of the saline controls, and normalized to the respectiv
arried out as described in Experimental Procedures. Test: ANOVA on
nalysis. Rats were habituated to the test environment for at least 30
sing a plantar test apparatus, to obtain a baseline level of response.
ithdrawal latencies were measured at 30, 60, 90 and 120 min aft
evelopment of thermal hyperalgesia. Intrathecal PP2 treatment (73 nm
t any time point (ns vs. PP2-saline baseline). As expected, intrathecal
rior administration of PP2 prevented the effect of ephrinB2-Fc in a
atencies which were intermediate between those of control (n7) and ephrinB2
hile a dose of 73 nmol totally prevented ephrinB2- induced hyperalgesia (ns.he effect of ephrinB2 upon NMDA receptors. We conse-
uently investigated the state of phosphorylation of the
yr418 residue of Src-family kinases with identical con-
erved regions (Src, Fyn and Yes) co-precipitated with
R2B. Following immunoprecipitation of NR2B, mem-
ranes were probed with anti-phospho-Tyr418. We did not
eprobe for amounts of total Src/Fyn/Yes as total levels of
hose proteins bound to NR2B are directly affected by
hosphorylation, i.e. phosphorylation promotes the asso-
iation of the proteins to NR2B (Yu et al., 1997); the ratio
f phospho-Src/total Src could thus potentially remain con-
tant despite a significant increase in the total amount of
ctivated phospho-Src bound to NR2B. We therefore
hose to reprobe for total levels of NR2B. Phosphorylation
evels of Src-family kinases bound to NR2B were signifi-
antly elevated following ephrinB2-Fc application onto the
orsal horn (Fig. 2A).
We wished to correlate those biochemical findings with
ehavioral studies. As previously shown (Battaglia et al.,
003), intrathecally administered ephrinB2-Fc induced
hermal hyperalgesia (Fig. 2B) (P0.01, n5). Prior ad-
inistration of the Src-family kinase inhibitor PP2 pre-
ented the onset of the ephrinB2-induced hyperalgesia in
dose-dependent manner: animals treated with PP2 at a
ose of 7.3 nmol displayed latencies which were interme-
iate between those of control and ephrinB2-treated rats
c bound to NR2B and on rat behavior in the plantar test. The animals
The first injection consisted of 10 l of either DMSO 10% in saline or
diluted in DMSO 10% saline), followed by a second injection of 10 l
cipitated from lysates of the dorsal horn of the lumbar spinal cord of
antibodies against phospho-Src (top) and NR2B (bottom). The levels
treated with ephrinB2-Fc (n4) as compared with control rats (n4).
rt the relative phosphoproteins level (meansS.E.M.) are expressed
band. The levels of total NR2B remained unchanged. Quantification
P0.05. (B) We correlated these biochemical findings with behavioral
withdrawal latency to a radiant thermal stimulus was then measured
als received then two intrathecal injections as described above. Paw
jections. A significant reduction in withdrawal latency indicated the
llowed by saline had no significant effect on paw withdrawal latencies
-Fc induced thermal hyperalgesia (P0.001, n5; two-way ANOVA).
endent manner: animals treated with 7.3 nmol PP2 (n6) displayedspho-Sr
interval).
ral testing
munopre
ed with
d in rats
e bar cha
e NR2B
ranks. *
min; their
The anim
er the in
ol/rat) fo
ephrinB2
dose-dep-Fc-treated rats, with significant hyperalgesia at 60 min only (P0.05),
vs. control, n7).
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S. Slack et al. / Neuroscience 156 (2008) 175–183 179n6), and significantly lower than control latencies, how-
ver only at 60 min (Fig. 2B), while a dose of 73 nmol
otally prevented the hyperalgesia induced by ephrinB2
latencies after injection not significantly different from con-
rol rats and baseline, n7) (Fig. 2B). Control rats (injected
ith PP2 73 nmol followed by saline) remained unchanged
hroughout the experiment (all time points not significantly
ifferent from baseline, Fig. 2B) (n7).
equestration of ephrinB2 following chronic
nflammatory pain in the cord prevents the rise in
R2B phosphorylation
he above biochemical and behavioral findings provide
nformation into the role of exogenously applied ephrinB2-
c. A physiological model of nociception was indispens-
ble to validate these data and a model of chronic inflam-
atory nociception induced by injecting carrageenan in the
ind paw was chosen. Forty minutes following the noxious
timulation induced by carrageenan injection a marked
nd significant increase in the state of pY-NR2B was ob-
ig. 3. Intrathecal administration of EphB1-Fc can prevent the in-
rease in tyrosine phosphorylation of NR2B induced by intraplantar
njection with carrageenan. Rats received an intraplantar injection of
arrageenan (1 mg/ml, 100 l), preceded by intrathecal injection with
ither EphB1-Fc (10 g/rat in saline, 10 l) or Human-Fc in saline
2 g/rat in 10 l). After 40 min the lumbar portion of their spinal cords
as dissected, and NR2B was immunoprecipitated from the dorsal
ortion of the cords. The top panel shows representative immunoblots
sing anti-phosphotyrosine 4G10 (pY-NR2B) and anti-NR2B antibod-
es. Forty minutes following the noxious stimulation induced by carra-
eenan injection there was a marked and significant increase in the
tate phosphorylation of NR2B (pY-NR2B). Intrathecal administration
f the soluble Eph-B1 receptor chimera prior to the carrageenan
njection significantly reduced the phosphorylation levels of NR2B.
evels of total NR2B remained unchanged. This suggests that the
ndogenous ephrin in the dorsal horn was prevented from binding to
phBs in the spinal cord by the soluble receptor, hence preventing the
hosphorylation of NR2B induced by carrageenan. In the bar chart the
elative phosphoproteins level (meansS.E.M.) are expressed as per-
entage of the saline controls, and normalized to the respective NR2Bp
and. Quantification carried out as described in Experimental Proce-
ures. Test: ANOVA on ranks. * P0.05.erved in the lumbar area of the dorsal horn of the cord
Fig. 3). Levels of total NR2B remained unchanged. Intra-
hecal administration of the soluble Eph-B1 receptor chi-
era prior to the carrageenan injection significantly re-
uced the phosphorylation levels of NR2B (Fig. 3). This
uggests that the interaction of endogenous ephrin with
phB receptors on dorsal horn neurons was prevented by
he soluble receptor, hence preventing the phosphorylation
f NR2B induced by carrageenan.
MDA and EphB1 receptor are present in the same
omplex
e previously demonstrated that ephrinB2 induces a hy-
eralgesic response and that carrageenan-induced hyper-
lgesia could be reduced with a soluble Eph-B1 chimera,
hich, however, due to the promiscuous binding of EphB
eceptors, could block the activation by endogenous
phrinB2 of any EphB receptor present in the spinal cord. It
emained therefore to be determined which Eph-B receptor
as mediating those effects. Eph-B1 is present in the adult
pinal cord dorsal horn neurons (Battaglia et al., 2003),
ph-B2 is found in meningeal fibroblasts of the spinal cord
Bundesen et al., 2003), while Eph-B3 is found in low
mount in normal animals, but is upregulated in white
atter astrocytes and motoneurons following a spinal cord
njury (Miranda et al., 1999). We therefore here investi-
ated whether Eph-B1 could be the receptor responsible
or ephrinB2 signaling to NR2B. We were able to co-
mmunoprecipitate Eph-B1 with NR2B (Fig. 4). We can
herefore conclude that the two receptors are at least in
lose association in the membrane of dorsal horn neurons.
DISCUSSION
he role of the NMDA receptor in the phenomenon of
ctivity-dependent synaptic plasticity is well established,
nd NMDA-mediated synaptic plasticity has been shown to
e essential for the development of chronic inflammatory
ig. 4. NR2B and EphB1 receptors co-immunoprecipitate. The lum-
ar region of the spinal cord of naive rats was dissected, and NR2B
as immunoprecipitated. Representative immunoblots obtained using
ntibodies against EphB1 receptor. We were able to co-immunopre-
ipitate Eph-B1 with NR2B (n5). We can therefore conclude that the
wo receptors are in close association in the membrane of dorsal horn
eurons.ain and neuropathic pain (see e.g. Petrenko et al., 2003).
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S. Slack et al. / Neuroscience 156 (2008) 175–183180MDA receptor function can be modulated by phosphory-
ation mechanisms (and in particular tyrosine phosphory-
ation, Ali and Salter, 2001; Salter and Kalia, 2004) by
eighboring activated receptors including TrkB, mGluRs
nd the NMDA receptor itself (Woolf and Salter, 2000; Guo
t al., 2004; Mantyh and Hunt, 2004), both in the hip-
ocampus and in the spinal cord (Rosenblum et al., 1996;
uo et al., 2002). However, the relative importance of the
ifferent pathways, and the different role of the multiple
MDA receptor subunits, is still controversial, and it is not
lear if the same mechanism is involved in the different
orms of chronic pain. Studies in recent years (reviewed in
ogas, 2006) have focused on the role of the NR2B sub-
nit of the receptor, which is important for receptor local-
zation and endocytosis, in pathological pain states. There
re some findings (Guo et al., 2002; Abe et al., 2005)
hich suggest a role for NR2B tyrosine phosphorylation in
nflammatory and neuropathic pain (even if the role of
R2B specific antagonists in analgesia has also been
ttributed to supraspinal, rather than intraspinal effects).
Here we provide evidence for the role of a further
eceptor, the EphB receptor, in controlling the phosphory-
ation of NMDA receptor in the spinal cord in vivo, acting on
he NR2B subunit. We had previous evidence for a role for
he EphB receptor in synaptic plasticity in vivo in the spinal
ord, which we proposed could be mediated by NMDA
eceptors (Battaglia et al., 2003). Immunohistochemical
tudies revealed expression of EphB1 receptors in neu-
ons in the dorsal horn and of the ligand ephrinB2 on small
ociceptive neurons (both at the level of the cell body and
n terminals in the dorsal horn). Activation of EphB recep-
or via intrathecal injection of EphrinB2-Fc chimeras in-
uced behavioral thermal hyperalgesia in freely moving
ats, which could be counteracted by prior injection of the
on-competitive NMDA receptor antagonist MK801, sug-
esting an involvement of the NMDA receptor. The mech-
nism apparently involved Src family kinases, since the
evel of phospho-Src bound to EphB receptors in the dorsal
orns of the spinal cord was increased. Conversely, block-
ge of EphB receptor activation by endogenous ephrin via
njection of EphB1-Fc chimeras was sufficient to inhibit the
nset of thermal hyperalgesia and mechanical allodynia in
model of inflammatory pain (carrageenan injection), on-
et which is presumed to require sensitization of neurons
n the dorsal horn, and significantly reduced pain-related
ehavior in the second phase of the formalin test (a model
f chemically induced pain), which again requires central
ensitization. The increase in c-fos expression in the su-
erficial laminae of the spinal cord in this model was also
nhibited.
In the present study we provide more direct evidence
upporting the hypothesis of a role of EphB receptors in
hysiological synaptic plasticity in vivo, via modulation of
MDA receptor activity, and in particular via Src-mediated
hosphorylation of the NR2B subunit. We first showed that
ntrathecal injection of ephrinB2-Fc chimeras, which in-
uces thermal hyperalgesia, also induced NR2B phos-
horylation on one or more tyrosine residues, including
yrosine 1472. The Tyr1472 residue was shown to be rhosphorylated in vivo in the hippocampus following LTP,
onfirming a role for this residue in synaptic plasticity (Na-
azawa et al., 2001). Furthermore phosphorylation of
yr1472 seems crucial for the maintenance of neuropathic
ain (Abe et al., 2005) and is one of the residues required
or EphB2-mediated NMDA receptor opening in cultured
ortical neurons (Takasu et al., 2002), indicating a possible
echanism for the modulatory effect of tyrosine phosphor-
lation on receptor function. Both the behavioral thermal
yperalgesia and NR2B phosphorylation were inhibited in
dose-dependent manner in the present work by preced-
ng ephrinB2-Fc injection with injection of the Src family
nhibitor PP2. We also showed that blockage of endoge-
ous EphB receptor activation by intrathecal injection with
phB1-Fc chimeras, which we had previously shown to
nhibit the behavioral and thermal hyperalgesia induced by
arrageenan injection in the hind paw (Battaglia et al.,
003), also inhibited the phosphorylation of NR2B induced
y this injection. It must be noted that Caudle et al. (2005)
id not observe an increase in NR2B phosphorylation in
arrageenan-treated rats, in contrast to our present find-
ngs in the same model, and those obtained by Guo et al.
2002) after complete Freund’s adjuvant or mustard oil
pplication. The reasons for this discrepancy are not clear.
he most likely explanation is a difference in the time
oints examined, and possibly in the protocol used to
uantify NR2B phosphorylation.
Previous studies (extensively reviewed in Caló et al.,
006) had suggested a role for the EphB2 receptor in
odulating the function of NMDA receptor in the hip-
ocampus, affecting both LTP and LDP, analogous to the
ole we now propose for Eph receptors in the spinal cord.
owever, these studies (Henderson et al., 2001; Grunwald
t al., 2001) were conducted in transgenic mice, therefore
evelopmental defect could not be excluded, and the
echanism of action in vivo could not be identified with
ertainty. Takasu et al. (2002), working with cultured em-
ryonic cortical neurons, established that EphB receptor
ctivation in these neurons, obtained with treatment with
phrinB2-Fc chimeras, induced Src family kinases phos-
horylation at residue Tyr416, with consequent NR2B re-
eptor phosphorylation and increased Ca2 influx through
MDA receptors upon glutamate administration. They also
howed that in HEK293T cells mutation of the Src-binding
ite on EphB2 or expression of a dominant negative of Fyn
inhibiting Src family kinases) disabled the phosphorylation
f NR2B effect of ephrinB2 and the potentiation of NMDA
eceptor activity.
Both our present findings and those by Guo et al.
2002) suggest that, in analogy to what shown by Takasu
t al. (2002) in cultured embryonic neurons, a Src family
inase is responsible for the tyrosine phosphorylation of
R2B in inflammatory pain. Evidence exists for a role at
east of Fyn and Src in NMDA receptor phosphorylation
Salter and Kalia, 2004), therefore we cannot exclude that
combination of at least these two Src family kinases is
esponsible for ephrinB2-mediated NR2B phosphorylation
n our spinal cord plasticity model. Nakazawa et al. (2001)
eported 25 tyrosine residues at the carboxyl tail of NR2B
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S. Slack et al. / Neuroscience 156 (2008) 175–183 181hich could be phosphorylated by Fyn, including Tyr1252,
yr1336, and Tyr1472 residues. We do not know how
any of these residues are phosphorylated in our model,
urther to Tyr1472. For an extensive review on the role of
rc family kinases in NMDA-dependent synaptic plasticity,
ee (Kalia et al., 2004).
Other subunits of the NMDA receptor may be targeted
y Src-family kinases (Ali and Salter, 2001). Indeed,
phB2 activation of Src by phosphorylation in cultured
ippocampal and cortical neurons could induce NR2A
hosphorylation (Grunwald et al., 2001). However NR2A
hosphorylation was unchanged following complete
reund’s adjuvant-induced noxious stimulation, suggest-
ng it is unlikely that this subunit has a role in hyperalgesia
Guo et al., 2002). NR2A and NR2B subunits seem to have
ifferent distribution in the spinal cord, and this may reflect
difference in function (Nagy et al., 2004).
In the present study we have exclusively investigated
he interaction between EphB receptor activation and
MDA phosphorylation. We cannot exclude a contribution
f NMDA receptor regulation via mechanisms other than
yrosine phosphorylation. Furthermore, we cannot exclude
he possibility that EphB receptor activation may regu-
ate the function of other receptors, further to the NMDA
eceptor. EphB receptors could potentially regulate AMPA
eceptor trafficking (reviewed in Caló et al., 2006).
An unavoidable limitation of the current study is that we
annot incontrovertibly identify the specific EphB receptor
esponsible for the effect we observed, due to the lack of
ppropriate tools to activate or inhibit individual EphB re-
eptors selectively. Here we show that EphB1 and NMDA
eceptors co-immunoprecipitate in dorsal spinal cord prep-
ration, indicating that they are associated in a complex,
ven if we do not know if they are directly physically
ssociated, as shown by Dalva et al. (2000) for EphB1-B4
nd the NR1 subunit of NMDA receptors in transfected
93T cells and cultured hippocampal neurons. Our current
nding, together with our previous immunohistochemical
ocalization data, and studies performed by us on EphB1
nockout mice, published only in abstract form (Cibert-
oton et al., 2005, 2006), support the hypothesis that
phB1 receptors are indeed involved in controlling synap-
ic plasticity at spinal cord level, possibly playing the same
ole that EphB2 plays in higher centers.
It remains to be determined whether the same mech-
nisms are also responsible for other chronic forms of
yperalgesia, such as those associated with nerve injury.
role for EphB1-ephrinB2 interactions in neuropathic pain
as recently been identified, providing further support to
he hypothesis that this receptor is the main contributor to
ynaptic plasticity of excitatory synapses in the spinal cord
Kobayashi et al., 2007; Song et al., 2008a,b). Kobayashi
t al. (2007) found that expression of ephrinB2 in dorsal
oot ganglion neurons was enhanced by nerve injury, and
phB1 receptor expression was observed in the dorsal
orn of the spinal cord of adult rat. Administration of
phrinB2 siRNA decreased expression of ephrinB2 and
echanical allodynia after spinal nerve crush. Song et al.2008a) studied the expression of ephrinB1 and EphB1 in she dorsal root ganglia and spinal cord after chronic con-
triction injury (a model of neuropathic pain), dorsal rhizo-
omy or a combination of both. Their findings, including a
ignificant upregulation of ephrinB1 and EphB1 in the spi-
al cord and dorsal root ganglia of adult rat after chronic
onstriction injury, which was time dependent and corre-
ated with the development of thermal hyperalgesia, sup-
ort the hypothesis of an involvement of this system in the
nset of neuropathic pain.
A very recent article by Song et al. (2008b), made
vailable online at the time of submission of the present
ork, adds further compelling support to the hypothesis of
n involvement of EphB receptor-ephrinB signaling in both
nset and maintenance of neuropathic pain. These au-
hors found that EphB1-Fc and EphB2-Fc chimeras, used
s blocking agents for EphB receptor activation, prevented
he onset of mechanical allodynia and thermal hyperalge-
ia, and transiently reversed established allodynia and
yperalgesia, in the chronic constriction injury model of
europathic pain. This behavioral observation correlated
ith parallel electrophysiological findings, that EphB-Fc
dministration prevented hyperexcitability of nociceptive
eurons in the dorsal root ganglion and sensitization of
ide dynamic range neurons in the dorsal horn in neuro-
athic rats. In the same model, activation of EphB recep-
ors with ephrinB-Fc in isolated dorsal root ganglia induced
yperexcitability of small nociceptive neurons, but only in
njured animals. Interestingly, the authors also found that
ctivation of EphB receptors promotes LTP of synapses
etween nociceptive dorsal root ganglion neurons and
orsal horn neurons in intact rats: this mechanism could
lso contribute to the role of the EphB-ephrinB system in
nflammatory pain.
The evidence presented here, together with previously
eported findings described above (Battaglia et al., 2003;
obayashi et al., 2007; Song et al., 2008a,b) would sug-
est that the interaction of presynaptic ephrinB2 (and in
europathic pain also possibly ephrinB1) with EphB recep-
ors is required for the onset of different forms of persistent
ain (both inflammatory and neuropathic). Our findings
Battaglia et al., 2003, and present work) support the idea
f an activation by ephrinB2 of postsynaptic EphB recep-
ors in neurons of the dorsal horn, since we showed that
phB1 receptors are present in dorsal horn neurons,
here they are found in close association with NMDA
eceptors, and intrathecal administration of ephrinB2-Fc
nduces an increase in phosphorylated Src kinase associ-
ted with the EphB receptor itself. Src phosphorylation is
equired for phosphorylation of the NR2B subunit of the
MDA receptor and for induction of thermal hyperalgesia
y ephrinB2. The mechanism we proposed for a physio-
ogical role of ephrinB2 in inflammatory hyperalgesia and
llodynia (Battaglia et al., 2003) was a rapid increase in the
xpression of ephrinB2 in the presynaptic membrane, with
onsequent clustering and activation of EphB receptors
ostsynaptically. The study by Kobayashi et al. (2007) and
ong et al. (2008a,b) would suggest that in more chronic
orms of pain this may be accompanied by an increase in
ynthesis of the ephrinB molecule. The article by Song et
a
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S. Slack et al. / Neuroscience 156 (2008) 175–183182l. (2008b) introduces the interesting possibility of a pre-
ynaptic site of action for EphB receptor activation, which
owever seems to require injury of dorsal root ganglion
eurons, followed by upregulation of the EphB1 receptor in
he ganglion. We found no evidence of expression of
phB1 in small nociceptive neurons in intact rats (Battaglia
t al., 2003); it is therefore possible that EphB activation in
ociceptive neurons occurs only after nerve injury. How-
ver, binding of ephrinB2 on nociceptive neurons to EphB1
n dorsal horn neurons could itself trigger reverse signaling
n nociceptors, since ephrinB2 activation can activate in-
racellular signaling cascades, and in other systems this
orm of retrograde signaling has been shown to regulate
ynaptic activity (reviewed in Caló et al., 2006). While
ctivation of ephrinB2 by EphB1 in intact animals does not
ppear to occur, or if it does occur it appears to have no
unctional consequences, since we (Battaglia et al., 2003)
bserved no change in thermal and mechanical sensitivity
fter intrathecal administration of EphB1 in control rats, it is
ossible that in animals sensitized by inflammation or in-
ury retrograde signaling in nociceptors does take place.
ur findings do not allow us to either confirm or exclude
his possibility.
CONCLUSION
n conclusion, the findings presented here add to our un-
erstanding of the function of the EphB receptors–ephrin
ystem in the adult nervous system in vivo (Yamaguchi
nd Pasquale, 2004), as important players in activity-de-
endent synaptic plasticity, acting as modulators of NMDA
eceptor function in vivo in the spinal cord. Furthermore,
ur results contribute to develop our understanding of the
echanisms underlying the phenomenon of central sensi-
ization in the spinal cord, which has been hypothesized to
e necessary for the onset and maintenance of forms of
hronic pain, supporting the view of a role for phosphory-
ation of spinal NR2B in inflammatory pain, first shown by
uo et al. (2002).
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